Two-drug regimens for HIV treatment
- 26 October 2022
- journal article
- review article
- Published by Elsevier in The Lancet HIV
- Vol. 9 (12) , e868-e883
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trialThe Lancet Infectious Diseases, 2014
- Antiretroviral reductionAIDS, 2014
- Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 studyJournal of Antimicrobial Chemotherapy, 2014
- Systemic Effects of Inflammation on Health during Chronic HIV InfectionImmunity, 2013
- Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study)Journal of Antimicrobial Chemotherapy, 2013
- A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study ResultsHIV Research & Clinical Practice, 2012
- Summary Report from the Human Immunodeficiency Virus and Aging Consensus Project: Treatment Strategies for Clinicians Managing Older Individuals with the Human Immunodeficiency VirusJournal of the American Geriatrics Society, 2012
- Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)AIDS, 2011
- Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical careAIDS, 2011
- A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patientsJournal of Antimicrobial Chemotherapy, 2009